
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systematic analyses of the resistance potential of drugs targeting SARS-CoV-2 main protease
Julia M. Flynn, Qiu Yu J. Huang, Sarah N. Zvornicanin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Julia M. Flynn, Qiu Yu J. Huang, Sarah N. Zvornicanin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Showing 5 citing articles:
Fitness effects of mutations to SARS-CoV-2 proteins
Jesse D. Bloom, Richard A. Neher
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 31
Jesse D. Bloom, Richard A. Neher
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 31
Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance
Julia M. Flynn, Sarah N. Zvornicanin, Tenzin Tsepal, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1174-1184
Closed Access | Times Cited: 7
Julia M. Flynn, Sarah N. Zvornicanin, Tenzin Tsepal, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1174-1184
Closed Access | Times Cited: 7
A comprehensive study of SARS-CoV-2 mfigain protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system
Francesco Costacurta, Andrea Dodaro, David Bante, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012522-e1012522
Open Access | Times Cited: 1
Francesco Costacurta, Andrea Dodaro, David Bante, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012522-e1012522
Open Access | Times Cited: 1
Naringenin-7-O-glucoside: Targeting SERPINE1, MMP7, and MMP1 for COVID-19 Lung Pathology and Immune Modulation
Vibha Mishra, Shivangi Agrawal, Divya Malik, et al.
(2023)
Open Access | Times Cited: 1
Vibha Mishra, Shivangi Agrawal, Divya Malik, et al.
(2023)
Open Access | Times Cited: 1
Contributions of hyperactive mutations in Mprofrom SARS-CoV-2 to drug resistance
Julia M. Flynn, Sarah N. Zvornicanin, Ala M. Shaqra, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Julia M. Flynn, Sarah N. Zvornicanin, Ala M. Shaqra, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access